Pediatrix Medical Group (NYSE:MD) PT Lowered to $14.00

Pediatrix Medical Group (NYSE:MD – Get Rating) had its price objective reduced by equities researchers at Deutsche Bank Aktiengesellschaft from $15.50 to $14.00 in a note issued to investors on Wednesday, The Fly reports. Deutsche Bank Aktiengesellschaft’s price objective points to a potential upside of 7.53% from the company’s previous close. A number of other […]

Related Keywords

Rogerj Medel , ,Pediatrix Medical Group Stock Down ,Credit Suisse Group ,Pediatrix Medical Group ,Pediatrix Medical Group Inc ,Tudor Investment Corp Et Al ,Grantham Mayo Van Otterloo Co ,Segall Bryant Hamill ,Redwood Investment Management ,News Ratings For Pediatrix Medical Group Daily ,Analyst Recommendations For Pediatrix Medical Group ,Deutsche Bank Aktiengesellschaft ,Pediatrix Medical Group Company Profile ,Get Rating ,Bank Aktiengesellschaft ,Suisse Group ,Medical Group Stock Down ,Medical Group ,Mayo Van Otterloo ,Investment Management ,Brandes Investment Partners ,Investment Partners ,Pediatrix Medical Group Daily ,Nyse Md ,Wmd ,Medical ,58502b10 ,Lower Price Target ,